Amr, Ali
Koelemen, Jan
Reich, Christoph
Sedaghat-Hamedani, Farbod
Kayvanpour, Elham
Haas, Jan
Frese, Karen
Lehmann, David
Katus, Hugo A.
Frey, Norbert
Meder, Benjamin http://orcid.org/0000-0003-0741-2633
Funding for this research was provided by:
Deutsches Zentrum für Herz-Kreislaufforschung
Deutsche Forschungsgemeinschaft
Informatics for Life
ERA-CVD network DETECTIN-HF
Daichii Sankyo
Else-Kröner Exzellenzstipendium
Universitätsklinikum Heidelberg
Article History
Received: 27 January 2023
Accepted: 14 September 2023
First Online: 4 October 2023
Declarations
:
: The authors declare no competing financial interests beyond the acknowledged third-party funding. BM was speaker of the working group for cardiomyopathies of the German Society of Cardiology. He receives speaker honorary and conducts advisory services for HCM-related therapies. BM and JH out-licensed genotyping methods and panel designs for cardiomyopathy to Agilent Inc.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Medical Faculty of the University of Heidelberg.